lamivudine has been researched along with Leukemia, Myeloid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chien, RN; Hsieh, SY; Kuo, MC; Liaw, YF; Shih, LY; Wang, PN; Yeh, CT | 1 |
| Chen, PM; Chiou, TJ; Hsiao, LT; Lee, MY; Lin, PC; Poh, SB | 1 |
| Motta, M; Pelizzari, A; Puoti, M; Rossi, G | 1 |
3 other study(ies) available for lamivudine and Leukemia, Myeloid
| Article | Year |
|---|---|
Acute leukaemia in chronic hepatitis B patients with lamivudine therapy.
Topics: Acute Disease; Adult; Female; Hepatitis B, Chronic; Humans; Lamivudine; Leukemia, Myeloid; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2004 |
Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients.
Topics: Acute Disease; Adult; Anti-HIV Agents; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Leukemia, Myeloid; Liver Failure, Acute; Lymphoma, Non-Hodgkin; Male | 2005 |
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hodgkin Disease; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Vidarabine; Vincristine; Virus Activation | 2001 |